BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24222902)

  • 1. Albumin reduces paracentesis-induced circulatory dysfunction and reduces death and renal impairment among patients with cirrhosis and infection: a systematic review and meta-analysis.
    Kwok CS; Krupa L; Mahtani A; Kaye D; Rushbrook SM; Phillips MG; Gelson W
    Biomed Res Int; 2013; 2013():295153. PubMed ID: 24222902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: A systematic review and meta-analysis.
    Shrestha DB; Budhathoki P; Sedhai YR; Baniya R; Awal S; Yadav J; Awal L; Davis B; Kashiouris MG; Cable CA
    Ann Hepatol; 2021 Dec; 26():100547. PubMed ID: 34626828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.
    Alessandria C; Elia C; Mezzabotta L; Risso A; Andrealli A; Spandre M; Morgando A; Marzano A; Rizzetto M
    Dig Liver Dis; 2011 Nov; 43(11):881-6. PubMed ID: 21741331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: Efficacy and safety of albumin in the prevention and treatment of complications in patients with cirrhosis.
    Leache L; Gutiérrez-Valencia M; Saiz LC; Uriz J; Bolado F; García-Erce JA; Cantarelli L; Erviti J
    Aliment Pharmacol Ther; 2023 Mar; 57(6):620-634. PubMed ID: 36524316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials.
    Bernardi M; Caraceni P; Navickis RJ; Wilkes MM
    Hepatology; 2012 Apr; 55(4):1172-81. PubMed ID: 22095893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials.
    Bai Z; Wang L; Wang R; Zou M; Méndez-Sánchez N; Romeiro FG; Cheng G; Qi X
    Hepatol Int; 2022 Dec; 16(6):1468-1483. PubMed ID: 36048318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.
    Ginès A; Fernández-Esparrach G; Monescillo A; Vila C; Domènech E; Abecasis R; Angeli P; Ruiz-Del-Arbol L; Planas R; Solà R; Ginès P; Terg R; Inglada L; Vaqué P; Salerno F; Vargas V; Clemente G; Quer JC; Jiménez W; Arroyo V; Rodés J
    Gastroenterology; 1996 Oct; 111(4):1002-10. PubMed ID: 8831595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insufficient evidence of benefit regarding mortality due to albumin substitution in HCC-free cirrhotic patients undergoing large volume paracentesis.
    Kütting F; Schubert J; Franklin J; Bowe A; Hoffmann V; Demir M; Pelc A; Nierhoff D; Töx U; Steffen HM
    J Gastroenterol Hepatol; 2017 Feb; 32(2):327-338. PubMed ID: 27149296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Tan HK; James PD; Wong F
    Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites.
    Sola-Vera J; Miñana J; Ricart E; Planella M; González B; Torras X; Rodríguez J; Such J; Pascual S; Soriano G; Pérez-Mateo M; Guarner C
    Hepatology; 2003 May; 37(5):1147-53. PubMed ID: 12717396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Albumin Infusion for the Management of Liver Cirrhosis and Its Complications: An Overview of Major Findings from Meta-analyses.
    Zheng X; Bai Z; Wang T; Romeiro FG; Mancuso A; Philips CA; Wong YJ; Nery FG; Qi X
    Adv Ther; 2023 Apr; 40(4):1494-1529. PubMed ID: 36697778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
    Hamdy H; ElBaz AA; Hassan A; Hassanin O
    J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study.
    Planas R; Ginès P; Arroyo V; Llach J; Panés J; Vargas V; Salmerón JM; Ginès A; Toledo C; Rimola A
    Gastroenterology; 1990 Dec; 99(6):1736-44. PubMed ID: 1699835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study.
    Singh V; Kumar B; Nain CK; Singh B; Sharma N; Bhalla A; Sharma AK
    J Intern Med; 2006 Jul; 260(1):62-8. PubMed ID: 16789980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral midodrine is comparable to albumin infusion in cirrhotic patients with refractory ascites undergoing large-volume paracentesis: results of a pilot study.
    Yosry A; Soliman ZA; Eletreby R; Hamza I; Ismail A; Elkady MA
    Eur J Gastroenterol Hepatol; 2019 Mar; 31(3):345-351. PubMed ID: 30312183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
    Singh V; Kumar R; Nain CK; Singh B; Sharma AK
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):303-7. PubMed ID: 16460491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial.
    Umgelter A; Reindl W; Wagner KS; Franzen M; Stock K; Schmid RM; Huber W
    Crit Care; 2008; 12(1):R4. PubMed ID: 18197961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paracentesis-Induced Circulatory Dysfunction With Modest-Volume Paracentesis Is Partly Ameliorated by Albumin Infusion in Acute-on-Chronic Liver Failure.
    Arora V; Vijayaraghavan R; Maiwall R; Sahney A; Thomas SS; Ali R; Jain P; Kumar G; Sarin SK
    Hepatology; 2020 Sep; 72(3):1043-1055. PubMed ID: 31849085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.
    Ginès P; Titó L; Arroyo V; Planas R; Panés J; Viver J; Torres M; Humbert P; Rimola A; Llach J
    Gastroenterology; 1988 Jun; 94(6):1493-502. PubMed ID: 3360270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colloids Versus Albumin in Large Volume Paracentesis to Prevent Circulatory Dysfunction: Evidence-based Case Report.
    Widjaja FF; Khairan P; Kamelia T; Hasan I
    Acta Med Indones; 2016 Apr; 48(2):148-55. PubMed ID: 27550886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.